Overview

Lymph Node Ratio and Kras Mutation in R Colon Cancer

Status:
Completed
Trial end date:
2019-08-26
Target enrollment:
Participant gender:
Summary
clinical impact of LN ratio with Kras expression in colon cancer
Phase:
Phase 3
Details
Lead Sponsor:
Mansoura University
Treatments:
Panitumumab